MALAT1 and hepatocellular carcinoma: Lai et al. (24) found that MALAT1 was overexpressed in 9 liver cancer cell lines and 112 HCC tissues, and survival analysis showed that patients with high level of MALAT1 had a significantly increased risk of recurrence after liver transplantation.